Company Encyclopedia
View More
name
IQVIA
IQV.US
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
770.89 B
IQV.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking17/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE19.55%A
    • Profit Margin8.07%B
    • Gross Margin33.49%C
  • Growth ScoreC
    • Revenue YoY3.85%C
    • Net Profit YoY-8.68%C
    • Total Assets YoY5.69%B
    • Net Assets YoY-9.75%D
  • Cash ScoreB
    • Cash Flow Margin1239.59%B
    • OCF YoY3.85%C
  • Operating ScoreB
    • Turnover0.57B
  • Debt ScoreE
    • Gearing Ratio78.11%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    IQVIA Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

    IQVIA Holdings Inc. stock fell 1.02% to $224.92 on Thursday, underperforming compared to competitors like HCA Healthcare and Centene Corp. The stock is 4% below its 52-week high of $234.30. The S&P 500 rose 0.11%, while the Dow Jones fell 0.07%. The data was compiled on December 4, 2025, by MarketWatch.

    Dow Jones·
    US
    IQV
    -1.02%
    Dow Jones·
    US
    IQV
    -1.02%

    FDA's new rule requiring one pivotal study caused fluctuations in biotech stocks: Medpace and Iqvia dropped, Viking Therapeutics rose.

    On Thursday, biotech stocks and research shares experienced different trajectories following reports indicating the FDA's imminent mandate of a single pivotal study. This development caused concerns for Medpace and Iqvia but resulted in gains for Viking Therapeutics. The potential policy change reflects a shift in regulatory requirements and could significantly impact the industry.

    Unusual Whales·
    US
    IQV
    -1.02%
    US
    MEDP
    -5.50%
    US
    VKTX
    +8.92%
    Unusual Whales·
    US
    IQV
    -1.02%
    US
    MEDP
    -5.50%
    US
    VKTX
    +8.92%

    Brandes Investment Partners LP Acquires New Position in IQVIA Holdings Inc. $IQV

    Brandes Investment Partners LP acquired 18,489 shares of IQVIA Holdings Inc. in Q2, valued at $2.914 million. Other investors also adjusted their stakes. IQVIA's stock opened at $225.76, with a market cap of $38.45 billion. The company reported Q3 earnings of $3.00 per share, beating estimates. Analysts have mixed ratings, with some upgrading to 'buy' and others downgrading to 'hold'. The stock has a consensus 'Moderate Buy' rating.

    Market Beat·
    US
    IQV
    -1.02%
    Market Beat·
    US
    IQV
    -1.02%

    Howmet Aerospace Inc. Stock Underperforms Tuesday When Compared To Competitors

    Howmet Aerospace Inc. (HWM) shares fell 1.25% to $196.26 on Tuesday, marking the third consecutive day of losses. Despite a positive trading session for the broader market, with the S&P 500 and Dow Jones rising, Howmet underperformed compared to competitors like Berkshire Hathaway and TransDigm Group. The stock is 7.40% below its 52-week high of $211.95, reached on October 30th. Trading volume was 2.6 million, above the 50-day average of 2.0 million.

    Dow Jones·
    US
    HWM
    +1.02%
    Dow Jones·
    US
    HWM
    +1.02%

    IQVIA Names AWS as Preferred Cloud Provider to Power Next-Gen AI Platform

    IQVIA Holdings Inc. has partnered with Amazon Web Services (AWS), naming AWS as its Preferred Cloud Provider. This collaboration aims to accelerate digital transformation in healthcare and life sciences by deploying IQVIA’s AI platform on AWS. The initiative will enhance automation in clinical trials, medical affairs, and healthcare analytics, speeding up drug innovation and treatment delivery. Both companies will explore new opportunities in life science analytics for data-driven insights and solutions.

    Reuters·
    US
    IQV
    -1.02%
    US
    AMZN
    -1.41%
    Reuters·
    US
    IQV
    -1.02%
    US
    AMZN
    -1.41%
    © 2025 Longbridge｜Disclaimer